Human rabies transmitted by vampire bats reached new heights in Latin America in 2005. A total of 55 human cases were reported in several outbreaks, 41 of them in the Amazon region of Brazil. Peru and Brazil had the highest number of reported cases from 1975 to 2006. In Peru, outbreaks involving more than 20 cases of bat-transmitted human rabies were reported during the 1980s and 1990s. During this period, a smaller number of cases were reported from outbreaks in Brazil. A comparison of data from field studies conducted in Brazil in 2005 with those from the previous decade suggests similar bat-bite situations at the local level. The objective of this study was to review the epidemiological situation and, on the basis of this information, discuss possible factors associated with the outbreaks. Prevention and control measures already recommended for dealing with this problem are also reviewed, and some further suggestions are provided.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1590/s1020-49892009000300010 | DOI Listing |
Zoonoses Public Health
December 2024
Department of Fish and Wildlife Conservation, Virginia Tech, Blacksburg, Virginia, USA.
Background: In Latin America, there is a high incidence of vampire bat-transmitted rabies in cattle causing increased mortality of livestock, which heavily impacts the agricultural sector. Anticoagulants-based control methods for the common vampire bat (Desmodus rotundus) have been employed continuously since the 1970s with various methods of application, presentations, doses and active ingredients. Studies from half a century ago still serve as a reference for the current use of anticoagulants for bat-borne rabies control in Latin America.
View Article and Find Full Text PDFTravel Med Infect Dis
December 2024
State Key Laboratory of Antibody Research &Development, Hebei Engineering Research Center of Antibody Medicine, North China Pharmaceutical Company New Drug Research and Development Co., Ltd., Shijiazhuang 050015, China. Electronic address:
Background: The combination of passive immune agents (human rabies immune globulin (HRIG) and equine rabies antiserum (ERA)) with vaccines are effective measures for preventing the onset of rabies post exposure. However, ERA and HRIG have potential risks of serum allergic reactions and blood-transmitted infectious diseases. This study compared the safety, pharmacokinetics and neutralizing activity of recombinant human anti-rabies monoclonal antibody NM57 injection (rhRIG, Ormutivimab) and HRIG in combination with rabies vaccine and vaccine alone.
View Article and Find Full Text PDFFront Health Serv
December 2024
School of Public Health, University of Rwanda, Kigali, Rwanda.
Uirusu
December 2024
Department of Microbiology, Faculty of Medicine and Research Center for Global and Local Infectious Diseases, Oita University, Oita, Japan.
Rev Med Inst Mex Seguro Soc
September 2024
Instituto Mexicano del Seguro Social, Coordinación de Calidad de Insumos y Laboratorios Especializados. Ciudad de México, México.
After the COVID-19 pandemic, efforts have gradually been focused on medical care, epidemiological surveillance, and preventive health programs. An example of this is the identification during 2023 by the Epidemiological Surveillance System [of Mexico] of the increase in dengue cases and the presence of serotype 3, as well as cases of measles (imported and related to importation) and, at the same time, cases of human rabies with transmission from pet animals. Mexico's health system has been characterized by achievements in vaccine-preventable pathologies, as well as the robust epidemiological surveillance system for febrile exanthematous illness and vector-transmitted diseases.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!